StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
PetMed Express, Inc.
NasdaqGS:PETS
Sector
Location
Market Cap
USD 67.96 M
Share Price
USD 3.29
Avg Daily Volume
158,425
Change (1 day)
-2.37%
Change (1 year)
-17.75%
Change (YTD)
-31.74%
PetMed Express, Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2024: USD 247.01 M
PetMed Express, Inc. Revenue is USD 247.01 M for the Trailing 12 Months (TTM) ending December 31, 2024, a -10.82% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
PetMed Express, Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2023 was USD 276.97 M, a 6.34% change year over year.
-
PetMed Express, Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2022 was USD 260.45 M, a -6.68% change year over year.
-
PetMed Express, Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2021 was USD 279.09 M, a -10.50% change year over year.
-
PetMed Express, Inc. Revenue for the Trailing 12 Months (TTM) ending December 31, 2020 was USD 311.82 M, a 13.64% change year over year.
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
McKesson Corporation
USD 719.30
MCK
+13.85
1.96%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
Elevance Health Inc.
USD 347.84
ELV
-2.41
-0.69%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Zoetis Inc.
USD 159.18
ZTS
+0.10
0.06%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Lonza Group AG
USD 698.01
LONN.SW
-5.41
-0.77%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%
Amgen Inc.
USD 298.52
AMGN
+1.67
0.56%
Pfizer Inc.
USD 25.39
PFE
+0.07
0.30%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 96.95
SAN.PA
-1.69
-1.71%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
McKesson Corporation
USD 719.30
MCK
+13.85
1.96%
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
Elevance Health Inc.
USD 347.84
ELV
-2.41
-0.69%
GSK plc
USD 19.04
GSK.L
-0.17
-0.91%
Zoetis Inc.
USD 159.18
ZTS
+0.10
0.06%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Cencora, Inc.
USD 296.23
COR
+5.06
1.74%
Lonza Group AG
USD 698.01
LONN.SW
-5.41
-0.77%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.47
600276.SS
+0.15
2.03%